Benzinga | Jul 20, 2020 08:06AM EDT

PolarityTE Announces Interim Data From Diabetic Foot Ulcer Trial Will Presented At Symposium On Advanced Wound Care To Be Held July 24-26, 2020

Company to Host Conference Call with Study Chair on Monday, July 27th at 4:30 pm ET

PolarityTE, Inc. (NASDAQ:PTE) announced that data from a protocol-specified interim analysis of the first 50 patients enrolled in a multi-center randomized controlled trial (RCT) entitled "SkinTE(tm) in the Treatment of Diabetic Foot Wounds" will be featured in a poster presentation at the Symposium on Advanced Wound Care (SAWC) Spring Virtual Conference to be held July 24-26, 2020. This study is a prospective, multi-center RCT designed to collect patient outcome data on SkinTE plus standard of care (SOC) versus SOC alone for the treatment of diabetic foot ulcers (DFUs). The primary endpoint is a comparison of the percent of index ulcers closed at 12 weeks. These data will be presented by the Study Chair, David Armstrong, DPM, MD, PhD, Professor of Surgery at the Keck School of Medicine of University of Southern California, and will be available to registrants of the SAWC Spring 2020 Virtual Conference to be held July 24-26, 2020. Details for the SAWC 2020 Virtual Conference can be found at https://www.sawcspring.com/.

PolarityTE will issue a press release announcing top-line data on Friday, July 24th at 8:00 am ET, and will also host a conference call and webcast to discuss the results with Dr. Armstrong at 4:30 pm ET on Monday, July 27th. The conference call can be accessed by calling 1-888-599-8688 (U.S. and Canada), with confirmation code 552780 and referencing "PolarityTE DFU Interim Data Conference Call." A webcast of the conference call can be accessed by using the link below.